Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.11.20.689600

Comparison of Brain Age Algorithms in Bipolar Disorder

Abstract

Advances in computational methods have accelerated the application of machine learning to analyze large complex biological data. By applying machine learning algorithms to neuroimaging data, researchers have estimated the "biological age of the brain" i.e., brain age, and used it as a composite metric for indexing brain health, as opposed to using individual features of the brain extracted from neuroimaging data. These machine learning algorithms/models, often known as "brain age" algorithms/models, may take supervised or unsupervised approaches and may utilize one or many imaging modalities during training. We applied 3 regression-based algorithm and 1 neural network-based algorithm trained on varying sample sizes of healthy comparison (HC) participants to estimate the brain age of 73 HC and 44 individuals with bipolar disorder (BD) in our neuroimaging study. Out of the four, 3 were pre-trained off-the-shelf algorithms and1 was developed and trained on multimodal neuroimaging data from a local cohort. The multimodal algorithm was trained on 51 age-matched HCs and tested on the remaining 22 HCs and 44 BDs. The brain predicted age difference (brain-PAD) score was calculated by subtracting the chronological age from the predicted age. Across four brain age prediction algorithms evaluated in HC, BrainageR and DenseNet demonstrated the highest predictive accuracy (r = 0.83; 0.89) and lowest mean absolute errors (MAE = 5.94; 7.26). However, PHOTON (r = 0.65, MAE = 7.71) showed greatest sensitivity to BD as demonstrated by our logistic regression model where the PHOTON brain-PAD was a significant predictor (beta = 0.064, p < 0.05) of BD. Analyses using ICC revealed that agreement levels varied, with PHOTON achieving the highest ICC with DenseNet (0.78) and BrainageR (0.73), which suggests they may pick up similar brain features as opposed to the multimodal algorithm (0.17- 0.43) These results suggest that regularized linear models trained on large samples that explicitly exclude individuals with psychiatric diagnoses (i.e., PHOTON in this case) may be most sensitive to case-control differences despite having lower predictive accuracy. Our findings can serve as a starting point and quantitative reference for future efforts for researchers working with datasets that are similarly constrained by sample size but include unique combinations of imaging modalities.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ng, H. X., Eyler, L.. 2025-11-21. Comparison of Brain Age Algorithms in Bipolar Disorder. https://doi.org/10.1101/2025.11.20.689600

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗